Around 57 percent of the surveyed pharmacies in South Korea in 2020 stated that they saw a decrease of over-the-counter sales following the COVID-19 outbreak. Meanwhile, around 30 percent reported OTC sales increased particularly in common cold and cough drugs.
Impact of COVID-19 on over-the-counter (OTC) pharmacy sales in South Korea in 2020
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Top challenges for pharmaceutical companies during COVID-19 2020
- Basic Statistic Launch disruption on global pharmaceutical market due to coronavirus 2020-2025
- Premium Statistic Changes in outpatient prescriptions in Gwangju and Jeolla South Korea 2020
- Premium Statistic Impact of COVID-19 on revenue of hospitality and retail sector South Korea 2020
- Premium Statistic Adjusted pharmaceutical sales forecast in South Korea 2020, by drug type
- Basic Statistic Merck & Co total assets 2009-2022
- Premium Statistic Novartis' revenue by region 2017-2022
- Basic Statistic Revenue of leading European pharmaceutical markets 2021
- Premium Statistic Changes in outpatient prescriptions in Daegu and Gyeongbuk South Korea 2020
- Premium Statistic Changes in outpatient prescriptions in Daejeon and Chungcheong South Korea 2020
About the region
10
- Premium Statistic Impact of COVID-19 on inbound tourist arrivals South Korea 2020
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Pharmaceuticals market size South Korea 2008-2021
- Premium Statistic Sales revenue Yuhan 2015-2022
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
Selected statistics
10
- Premium Statistic Merck & Co - expenditure on research and development 2006-2022
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2022
- Basic Statistic Sanofi's total assets 2007-2022
- Basic Statistic Merck & Co cash dividends declared 2006-2022
- Premium Statistic Sales of Johnson & Johnson 2006-2022 by region
- Premium Statistic Johnson & Johnson's number of employees 2004-2022
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2022, by segment
- Basic Statistic GSK's operating profit by division 2006-2021
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2022
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
Other regions
10
- Basic Statistic Moderna net income 2016-2022
- Basic Statistic YTD stock performance of biopharma companies working on COVID March 2020
- Premium Statistic Revenue value from biotechnology companies in Germany 2008-2021
- Basic Statistic Monthly number of valid applications for clinical trials in Denmark 2020
- Premium Statistic Market size of branded biopharmaceuticals in China 2013-2023
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Premium Statistic Leading pharmaceutical producing companies in Colombia 2021
- Basic Statistic Revenue of pharmaceutical markets in Central and Eastern Europe 2021
- Basic Statistic Annual revenue of Sobi 2009-2022
- Premium Statistic Leading European pharmaceutical companies by R&D spending 2022
Related statistics
10
- Premium Statistic Changes in outpatient prescriptions during COVID-19 in Seoul South Korea 2020
- Premium Statistic Impact of COVID-19 on pharmacy operations in South Korea 2020
- Premium Statistic Changes in outpatient prescriptions in Gyeonggi/Incheon/Gangwon South Korea 2020
- Premium Statistic Changes in outpatient prescriptions in Busan and Gyeongnam South Korea 2020
- Premium Statistic Leading pharmaceutical businesses South Korea 2022, by revenue
- Premium Statistic Revenue of GC Pharma 2015-2022
- Premium Statistic Revenue of Chong Kun Dang 2015-2022
- Premium Statistic Revenue of Samsung Biologics 2015-2022
- Premium Statistic Traditional medicine industry South Korea 2021, by sales revenue
- Premium Statistic Traditional medicine industry sales in South Korea 2021, by sector
Further related statistics
10
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- Medicinal market growth worldwide including rebates 2009-2018
- Pfizer's ad spending 2008-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- CVS Health's total assets 2005-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2022
Further Content: You might find this interesting as well
Statistics
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- Medicinal market growth worldwide including rebates 2009-2018
- Pfizer's ad spending 2008-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- CVS Health's total assets 2005-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2022
IQVIA. (March 31, 2020). Impact of COVID-19 on over-the-counter (OTC) pharmacy sales in South Korea in 2020 [Graph]. In Statista. Retrieved September 28, 2023, from https://www.statista.com/statistics/1120103/south-korea-covid-19-impact-on-otc-pharmacy-sales/
IQVIA. "Impact of COVID-19 on over-the-counter (OTC) pharmacy sales in South Korea in 2020." Chart. March 31, 2020. Statista. Accessed September 28, 2023. https://www.statista.com/statistics/1120103/south-korea-covid-19-impact-on-otc-pharmacy-sales/
IQVIA. (2020). Impact of COVID-19 on over-the-counter (OTC) pharmacy sales in South Korea in 2020. Statista. Statista Inc.. Accessed: September 28, 2023. https://www.statista.com/statistics/1120103/south-korea-covid-19-impact-on-otc-pharmacy-sales/
IQVIA. "Impact of Covid-19 on Over-the-counter (Otc) Pharmacy Sales in South Korea in 2020." Statista, Statista Inc., 31 Mar 2020, https://www.statista.com/statistics/1120103/south-korea-covid-19-impact-on-otc-pharmacy-sales/
IQVIA, Impact of COVID-19 on over-the-counter (OTC) pharmacy sales in South Korea in 2020 Statista, https://www.statista.com/statistics/1120103/south-korea-covid-19-impact-on-otc-pharmacy-sales/ (last visited September 28, 2023)
Impact of COVID-19 on over-the-counter (OTC) pharmacy sales in South Korea in 2020 [Graph], IQVIA, March 31, 2020. [Online]. Available: https://www.statista.com/statistics/1120103/south-korea-covid-19-impact-on-otc-pharmacy-sales/